It has been shown that chronic treatment with sEH inhibitors reduced the progression of post-MI LV systolic dysfunction in normotensive animals (Li et al., 2009; Merabet et al., 2012; Kompa et al., 2013; Sirish et al., 2013). Here, EPHX2 is linked to myocardial infarction.